These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32582101)

  • 1. Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products.
    Bretaudeau L; Tremblais K; Aubrit F; Meichenin M; Arnaud I
    Front Microbiol; 2020; 11():1161. PubMed ID: 32582101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
    Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Future of Clinical Phage Therapy in the United Kingdom.
    Jones JD; Trippett C; Suleman M; Clokie MRJ; Clark JR
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs.
    Abou-El-Enein M; Römhild A; Kaiser D; Beier C; Bauer G; Volk HD; Reinke P
    Cytotherapy; 2013 Mar; 15(3):362-83. PubMed ID: 23579061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality and safety requirements for sustainable phage therapy products.
    Pirnay JP; Blasdel BG; Bretaudeau L; Buckling A; Chanishvili N; Clark JR; Corte-Real S; Debarbieux L; Dublanchet A; De Vos D; Gabard J; Garcia M; Goderdzishvili M; Górski A; Hardcastle J; Huys I; Kutter E; Lavigne R; Merabishvili M; Olchawa E; Parikka KJ; Patey O; Pouilot F; Resch G; Rohde C; Scheres J; Skurnik M; Vaneechoutte M; Van Parys L; Verbeken G; Zizi M; Van den Eede G
    Pharm Res; 2015 Jul; 32(7):2173-9. PubMed ID: 25585954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control.
    Andriolo G; Provasi E; Brambilla A; Lo Cicero V; Soncin S; Barile L; Turchetto L; Radrizzani M
    Methods Mol Biol; 2021; 2286():131-166. PubMed ID: 33381854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good manufacturing practice for immunological veterinary medicinal products.
    Todd JI
    Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to achieve safe, high-quality clinical studies with non-Medicinal Investigational Products? A practical guideline by using intra-bronchial carbon nanoparticles as case study.
    Berger M; Kooyman PJ; Makkee M; van der Zee JS; Sterk PJ; van Dijk J; Kemper EM
    Respir Res; 2016 Aug; 17(1):102. PubMed ID: 27542842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of running a GMP facility for regenerative medicine in a public hospital.
    Viganò M; Giordano R; Lazzari L
    Regen Med; 2017 Oct; 12(7):803-813. PubMed ID: 29115906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Therapy in Germany-Update 2023.
    Willy C; Bugert JJ; Classen AY; Deng L; Düchting A; Gross J; Hammerl JA; Korf IHE; Kühn C; Lieberknecht-Jouy S; Rohde C; Rupp M; Vehreschild MJGT; Vogele K; Wienecke S; Witzenrath M; Würstle S; Ziehr H; Moelling K; Broecker F
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Approaches for the Production of Active Ingredient and Drug Product for Human Phage Therapy.
    Mutti M; Corsini L
    Front Microbiol; 2019; 10():2289. PubMed ID: 31649636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of Therapeutic Bacteriophages in Nosocomial Infection Management.
    Wu N; Zhu T
    Front Microbiol; 2021; 12():638094. PubMed ID: 33633717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of advanced therapy medicinal products in Europe and the role of academia.
    Pearce KF; Hildebrandt M; Greinix H; Scheding S; Koehl U; Worel N; Apperley J; Edinger M; Hauser A; Mischak-Weissinger E; Dickinson AM; Lowdell MW
    Cytotherapy; 2014 Mar; 16(3):289-97. PubMed ID: 24113428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration.
    Kropp M; Harmening N; Bascuas T; Johnen S; De Clerck E; Fernández V; Ronchetti M; Cadossi R; Zanini C; Scherman D; Ivics Z; Marie C; Izsvák Z; Thumann G
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of
    Ushanov L; Lasareishvili B; Janashia I; Zautner AE
    Animals (Basel); 2020 Feb; 10(2):. PubMed ID: 32054081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good manufacturing practice: the role of local manufacturers and competent authorities.
    Tomić S; Filipović Sučić A; Ilić Martinac A
    Arh Hig Rada Toksikol; 2010 Dec; 61(4):425-36. PubMed ID: 21183434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.